Sex and Gender Differences in Disease, Pharmacotherapy, and Clinical Outcomes: Implications for Precision Medicine
DOI:
https://doi.org/10.68041/jwhrmp.v1i1/05Keywords:
Drug Therapy, Pharmacogenetics, Precision Medicine, Sex Characteristics, Sex Factors, Therapeutics, Treatment OutcomeAbstract
Precision medicine hopes to make health care better by accounting for the variability of individuals' biology and clinical features in disease prediction and treatment. To achieve personalized care, however, it is essential that sex- and gender-related factors are recognized as they impact the mechanisms of disease, pharmacological actions and clinical outcomes. Disease susceptibility and response to treatment may differ between the sexes due to sex-related differences in genetics, hormones, immune regulation, epigenetic processes and metabolism; and diagnosis, access to healthcare, use of treatment and outcome may also differ across sex. There is growing evidence that considers sex and gender aspects in pharmacotherapy, discovery of biomarkers, artificial intelligence and multi-omics. Although this is starting to be recognized, there are still limitations of representation in clinical research, inconsistencies in how it is reported, and a lack of translation to clinical applications. This narrative review discusses the latest evidence regarding sex and gender differences in disease biology, pharmacotherapy, and clinical outcomes and their potential contribution to precision medicine. The incorporation of these factors into personalized health care systems can improve risk stratification, optimization of therapy, safety of drugs, and patient care.
References
1. Strianese O, Rizzo F, Ciccarelli M, Galasso G, D’Agostino Y, Salvati A, et al. Precision and personalized medicine: how genomic approach improves the management of cardiovascular and neurodegenerative disease. Genes (Basel). 2020;11(7):747. https://doi.org/10.3390/genes11070747 DOI: https://doi.org/10.3390/genes11070747
2. Mielke MM, Miller VM. Improving clinical outcomes through attention to sex and hormones in research. Nat Rev Endocrinol. 2021;17(10):625-635. https://doi.org/10.1038/s41574-021-00531-z DOI: https://doi.org/10.1038/s41574-021-00531-z
3. Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol. 2023;20(4):236-247. https://doi.org/10.1038/s41569-022-00797-4
4. Romanescu M, Buda V, Lombrea A, Andor M, Ledeti I, Suciu M, et al. Sex-related differences in pharmacological response to CNS drugs: a narrative review. J Pers Med. 2022;12(6):907. https://doi.org/10.3390/jpm12060907 DOI: https://doi.org/10.3390/jpm12060907
5. Shi Y, Ma J, Li S, Liu C, Liu Y, Chen J, et al. Sex difference in human diseases: mechanistic insights and clinical implications. Signal Transduct Target Ther. 2024;9(1):238. https://doi.org/10.1038/s41392-024-01929-7 DOI: https://doi.org/10.1038/s41392-024-01929-7
6. Bosch EL, Sommer IEC, Touw DJ. The influence of female sex and estrogens on drug pharmacokinetics: what is the evidence? Expert Opin Drug Metab Toxicol. 2025;21(6):637-647. https://doi.org/10.1080/17425255.2025.2481891 DOI: https://doi.org/10.1080/17425255.2025.2481891
7. Gogovor A, Zomahoun HTV, Ekanmian G, Adisso EL, Tardif AD, Khadhraoui L, et al. Sex and gender considerations in reporting guidelines for health research: a systematic review. Biol Sex Differ. 2021;12(1):62. https://doi.org/10.1186/s13293-021-00404-0
8. Hall M, Krishnanandan VA, Cheung MC, Coburn NG, Haas B, Chan KKW, et al. An evaluation of sex- and gender-based analyses in oncology clinical trials. Natl Cancer Inst. 2022;114(8):1186-1191. https://doi.org/10.1093/jnci/djac092 DOI: https://doi.org/10.1093/jnci/djac092
9. Arnold AP. X chromosome agents of sexual differentiation. Nat Rev Endocrinol. 2022;18(9):574-583. https://doi.org/10.1038/s41574-022-00697-0 DOI: https://doi.org/10.1038/s41574-022-00697-0
10. Dunn SE, Perry WA, Klein SL. Mechanisms and consequences of sex differences in immune responses. Nat Rev Nephrol. 2024;20(1):37-55. https://doi.org/10.1038/s41581-023-00787-w DOI: https://doi.org/10.1038/s41581-023-00787-w
11. Kuroki Y, Fukami M. Y chromosome genomic variations and biological significance in human diseases and health. Cytogenet Genome Res. 2023;163(1-2):5-13. https://doi.org/10.1159/000531933 DOI: https://doi.org/10.1159/000531933
12. Kundakovic M, Tickerhoof M. Epigenetic mechanisms underlying sex differences in the brain and behavior. Trends Neurosci. 2024;47(1):18-35. https://doi.org/10.1016/j.tins.2023.09.007 DOI: https://doi.org/10.1016/j.tins.2023.09.007
13. Gatev E, Inkster AM, Negri GL, Konwar C, Lussier AA, Skakkebaek A, et al. Autosomal sex-associated co-methylated regions predict biological sex from DNA methylation. Nucleic Acids Res. 2021;49(16):9097-9116. https://doi.org/10.1093/nar/gkab682 DOI: https://doi.org/10.1093/nar/gkab682
14. Vaura F, Palmu J, Aittokallio J, Kauko A, Niiranen T. Genetic, molecular, and cellular determinants of sex-specific cardiovascular traits. Circ Res. 2022;130(4):611-631. https://doi.org/10.1161/CIRCRESAHA.121.319891 DOI: https://doi.org/10.1161/CIRCRESAHA.121.319891
15. Manuel RSJ, Liang Y. Sexual dimorphism in immunometabolism and autoimmunity: impact on personalized medicine. Autoimmun Rev. 2021;20(4):102775. https://doi.org/10.1016/j.autrev.2021.102775 DOI: https://doi.org/10.1016/j.autrev.2021.102775
16. Chakraborty B, Byemerwa J, Krebs T, Lim F, Chang CY, McDonnell DP. Estrogen receptor signaling in the immune system. Endocr Rev. 2023;44(1):117-141. https://doi.org/10.1210/endrev/bnac017 DOI: https://doi.org/10.1210/endrev/bnac017
17. Visniauskas B, Kilanowski-Doroh I, Ogola BO, Mcnally AB, Horton AC, Imulinde Sugi A, et al. Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases. J Hum Hypertens. 2023;37(8):609-618. https://doi.org/10.1038/s41371-022-00771-0 DOI: https://doi.org/10.1038/s41371-022-00771-0
18. Kim YR, Jung Y, Kang I, Yeo EJ. Understanding sex differences in autoimmune diseases: immunologic mechanisms. Int J Mol Sci. 2025;26(15):7101. https://doi.org/10.3390/ijms26157101
19. Jiwrajka N, Anguera MC. The X in seX-biased immunity and autoimmune rheumatic disease. J Exp Med. 2022;219(6):e20211487. https://doi.org/10.1084/jem.20211487 DOI: https://doi.org/10.1084/jem.20211487
20. Forsyth KS, Jiwrajka N, Lovell CD, Toothacre NE, Anguera MC. The conneXion between sex and immune responses. Nat Rev Immunol. 2024;24(7):487-502. https://doi.org/10.1038/s41577-024-00996-9 DOI: https://doi.org/10.1038/s41577-024-00996-9
21. Horn C, Sprute R, Kretschmer AC, Do C, Cornely OA, Jung N, et al. Sex in infectious diseases—how sex differences influence the immune response to infections. Internist (Berl). 2023;64(8):752-757. https://doi.org/10.1007/s00108-023-01498-x
22. DiMarco M, Zhao H, Boulicault M, Richardson SS. Why “sex as a biological variable” conflicts with precision medicine initiatives. Cell Rep Med. 2022;3(4):100550. https://doi.org/10.1016/j.xcrm.2022.100550 DOI: https://doi.org/10.1016/j.xcrm.2022.100550
23. Edvardsson M, Heenkenda MK. Precision medicine: personalizing healthcare by bridging aging, genetics, and global diversity. Healthcare (Basel). 2025;13(13):1529. https://doi.org/10.3390/healthcare13131529 DOI: https://doi.org/10.3390/healthcare13131529
24. Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Med Nov Technol Devices. 2019;4(2):100025. https://doi.org/10.1016/j.medntd.2019.100025 DOI: https://doi.org/10.1016/j.medntd.2019.100025
25. Munjas J, Vladimirov S, Ratkovic T, Comi L, Giglione C, Tanaskovic I, et al. Toward precision medicine in atherosclerotic cardiovascular disease: insights from omics data into sex differences. Curr Atheroscler Rep. 2025;28(1):5. https://doi.org/10.1007/s11883-025-01380-1 DOI: https://doi.org/10.1007/s11883-025-01380-1
26. Fasero M, Coronado PJ. Cardiovascular disease risk in women with menopause. J Clin Med. 2025;14(11):3663. https://doi.org/10.3390/jcm14113663 DOI: https://doi.org/10.3390/jcm14113663
27. Barrell AM, Sferruzzi-Perri AN. The impact of preeclampsia and gestational diabetes on future maternal cardiometabolic health. Acta Physiol (Oxf). 2025;241(11):e70113. https://doi.org/10.1111/apha.70113 DOI: https://doi.org/10.1111/apha.70113
28. Lohana K, Parkash J, Shaikh MZ, Ghani M, Lohana N, Uqaili AA. To deduce the changes in lipid profile and BMI that lead to cardiovascular diseases in postmenopausal women. J Popul Ther Clin Pharmacol. 2023;30(19):1809–1814. https://doi.org/10.53555/jptcp.v30i19.3941
29. Kim YR, Jung Y, Kang I, Yeo EJ. Understanding sex differences in autoimmune diseases: immunologic mechanisms. Int J Mol Sci. 2025;26(15):7101. https://doi.org/10.3390/ijms26157101 DOI: https://doi.org/10.3390/ijms26157101
30. Kronzer VL, Bridges SL Jr, Davis JM III. Why women have more autoimmune diseases than men: an evolutionary perspective. Evol Appl. 2021;14(3):629-633. https://doi.org/10.1111/eva.13167 DOI: https://doi.org/10.1111/eva.13167
31. Cicero CE, Angelini L, Abbadessa G, Bruno M, Fiume G, Nucera B, et al. Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice. Neurol Sci. 2026;47(1):108. https://doi.org/10.1007/s10072-025-08623-8
32. Miramontes S, Pereda Serras C, Woldemariam SR, Khan U, Li Y, Tang AS, et al. Alzheimer’s disease as a women’s health challenge: a call for action on integrative precision medicine approaches. NPJ Womens Health. 2024;2(1):17. https://doi.org/10.1038/s44294-024-00021-3 DOI: https://doi.org/10.1038/s44294-024-00021-3
33. D’Anca M, Buccellato FR, Tartaglia GM, Del Fabbro M, Muti P, Scarpini E, et al. Why is multiple sclerosis more frequent in women? Role of the immune system and of oral and gut microbiota. Appl Sci. 2023;13(10):5881. https://doi.org/10.3390/app13105881 DOI: https://doi.org/10.3390/app13105881
34. Eckstrand KL, Travis MJ, Forbes EE, Phillips ML. Sex differences and personalized psychiatric care. Biol Psychiatry. 2016;80(10):e81-e83. https://doi.org/10.1016/j.biopsych.2016.09.009 DOI: https://doi.org/10.1016/j.biopsych.2016.09.009
35. Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Sex disparities matter in cancer development and therapy. Nat Rev Cancer. 2021;21(6):393-407. https://doi.org/10.1038/s41568-021-00348-y DOI: https://doi.org/10.1038/s41568-021-00348-y
36. Xiao T, Lee J, Gauntner TD, Velegraki M, Lathia JD, Li Z, et al. Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications. Nat Rev Cancer. 2024;24(6):338-355. https://doi.org/10.1038/s41568-024-00680-z
37. Horn C, Sprute R, Kretschmer AC, Do C, Cornely OA, Jung N, et al. Sex in infectious diseases—how sex differences influence the immune response to infections. Internist (Berl). 2023;64(8):752-757. https://doi.org/10.1007/s00108-023-01498-x DOI: https://doi.org/10.1007/s00108-023-01498-x
38. Olafuyi O, Parekh N, Wright J, Koenig J. Inter-ethnic differences in pharmacokinetics—is there more that unites than divides? Pharmacol Res Perspect. 2021;9(6):e00890. https://doi.org/10.1002/prp2.890 DOI: https://doi.org/10.1002/prp2.890
39. Aljohmani A, Yildiz D. Biological sex differences in pharmacokinetics and adverse drug reactions. Naunyn Schmiedebergs Arch Pharmacol. 2026;399(3):3285-3301. https://doi.org/10.1007/s00210-025-04721-8 DOI: https://doi.org/10.1007/s00210-025-04721-8
40. Gerges SH, El-Kadi AOS. Sexual dimorphism in the expression of cytochrome P450 enzymes in rat heart, liver, kidney, lung, brain, and small intestine. Drug Metab Dispos. 2023;51(1):81-94. https://doi.org/10.1124/dmd.122.000915 DOI: https://doi.org/10.1124/dmd.122.000915
41. Niu J, Straubinger RM, Mager DE. Pharmacodynamic drug-drug interactions. Clin Pharmacol Ther. 2019;105(6):1395-1406. https://doi.org/10.1002/cpt.1434 DOI: https://doi.org/10.1002/cpt.1434
42. Araújo M, Frias A, Silvestre R. Sex differences in immune modulation: implications for infection, inflammation, and nutritional supplementation. Biol Sex Differ. 2026;17(1). https://doi.org/10.1186/s13293-026-00857-1 DOI: https://doi.org/10.1186/s13293-026-00857-1
43. Irelli A, Sirufo MM, D’Ugo C, Ginaldi L, De Martinis M. Sex and gender influences on cancer immunotherapy response. Biomedicines. 2020;8(7):232. https://doi.org/10.3390/biomedicines8070232 DOI: https://doi.org/10.3390/biomedicines8070232
44. Brabete AC, Greaves L, Maximos M, Huber E, Li A, Lê ML. A sex- and gender-based analysis of adverse drug reactions: a scoping review of pharmacovigilance databases. Pharmaceuticals (Basel). 2022;15(3):298. https://doi.org/10.3390/ph15030298
45. Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020;11(1):32. https://doi.org/10.1186/s13293-020-00308-5 DOI: https://doi.org/10.1186/s13293-020-00308-5
46. Brabete AC, Greaves L, Maximos M, Huber E, Li A, Lê ML. A sex- and gender-based analysis of adverse drug reactions: a scoping review of pharmacovigilance databases. Pharmaceuticals (Basel). 2022;15(3):298. https://doi.org/10.3390/ph15030298 DOI: https://doi.org/10.3390/ph15030298
47. Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero JJ, Dakal S, Franconi F, et al. Sex- and gender-based pharmacological response to drugs. Pharmacol Rev. 2021;73(2):730-762. https://doi.org/10.1124/pharmrev.120.000206 DOI: https://doi.org/10.1124/pharmrev.120.000206
48. Labots G, Jones A, de Visser SJ, Rissmann R, Burggraaf J. Gender differences in clinical registration trials: is there a real problem? Br J Clin Pharmacol. 2018;84(4):700-707. https://doi.org/10.1111/bcp.13497 DOI: https://doi.org/10.1111/bcp.13497
49. Srivastav AK, Mishra MK, Lillard JW Jr, Singh R. Transforming pharmacogenomics and CRISPR gene editing with the power of artificial intelligence for precision medicine. Pharmaceutics. 2025;17(5):555. https://doi.org/10.3390/pharmaceutics17050555 DOI: https://doi.org/10.3390/pharmaceutics17050555
50. Lacroix C, Maurier A, Largeau B, Destere A, Thillard EM, Drici M, et al. Sex differences in adverse drug reactions: are women more impacted? Therapie. 2023;78(2):175-188. https://doi.org/10.1016/j.therap.2022.10.002 DOI: https://doi.org/10.1016/j.therap.2022.10.002
51. Lee KK, Doudesis D, Bing R, Astengo F, Perez JR, Anand A, et al. Sex differences in oral anticoagulation therapy in patients hospitalized with atrial fibrillation: a nationwide cohort study. J Am Heart Assoc. 2023;12(5):e027211. https://doi.org/10.1161/JAHA.122.027211 DOI: https://doi.org/10.1161/JAHA.122.027211
52. Xiao T, Lee J, Gauntner TD, Velegraki M, Lathia JD, Li Z. Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications. Nat Rev Cancer. 2024;24(5):338-355. https://doi.org/10.1038/s41568-024-00680-z DOI: https://doi.org/10.1038/s41568-024-00680-z
53. Plevkova J, Brozmanova M, Harsanyiova J, Sterusky M, Honetschlager J, Buday T. Various aspects of sex and gender bias in biomedical research. Physiol Res. 2020;69(Suppl 3):S367-S378. https://doi.org/10.33549/physiolres.934593 DOI: https://doi.org/10.33549/physiolres.934593
54. Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol. 2023;20(4):236-247. https://doi.org/10.1038/s41569-022-00797-4 DOI: https://doi.org/10.1038/s41569-022-00797-4
55. Cicero CE, Angelini L, Abbadessa G, Bruno M, Fiume G, Nucera B, et al. Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice. Neurol Sci. 2026;47(1):108. https://doi.org/10.1007/s10072-025-08623-8 DOI: https://doi.org/10.1007/s10072-025-08623-8
56. Jeffrey G. Barriers to women in accessing healthcare in the UK – a review. LSE Public Policy Rev. 2025;3(4):5:1-12. https://doi.org/10.31389/lseppr.122 DOI: https://doi.org/10.31389/lseppr.122
57. Religioni U, Barrios-Rodríguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina (Kaunas). 2025;61(1):153. https://doi.org/10.3390/medicina61010153 DOI: https://doi.org/10.3390/medicina61010153
58. Jamalinia M, Weiskirchen R. Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment. Ann Transl Med. 2025;13(2):18. https://doi.org/10.21037/atm-25-34 DOI: https://doi.org/10.21037/atm-25-34
59. Delgado J, Cano Abadía M, Akyüz K, Goisauf M, Rodríguez-Arias D. Uncovering the persistent gap: the ongoing challenge of integrating sex and gender in biomedical research. J Biomed Res. 2025;39(1):18-22. https://doi.org/10.7555/JBR.38.20240157 DOI: https://doi.org/10.7555/JBR.38.20240157
60. Gan Y, Tian R, Han S, Zeng H, Sun F. Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysis. J Natl Cancer Cent. 2026;6(3):274-285. https://doi.org/10.1016/j.jncc.2026.03.006 DOI: https://doi.org/10.1016/j.jncc.2026.03.006
61. Nielsen MW, Stefanick ML, Peragine D, Neilands TB, Ioannidis JPA, Pilote L, et al. Gender-related variables for health research. Biol Sex Differ. 2021;12(1):23. https://doi.org/10.1186/s13293-021-00366-3 DOI: https://doi.org/10.1186/s13293-021-00366-3
62. Le Bars S, Soudy M, Glaab E. XYomics: detecting sex-dependent molecular mechanisms in omics data. Nucleic Acids Res. 2026;54(14):gkag759. https://doi.org/10.1093/nar/gkag759 DOI: https://doi.org/10.1093/nar/gkag759
63. Kavousi M, van Lennep JR. Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative. Neth Heart J. 2023;31(10):369-370. https://doi.org/10.1007/s12471-023-01817-9 DOI: https://doi.org/10.1007/s12471-023-01817-9
64. Mezzalira S, Toffoli G. The effects of sex on pharmacogenetically guided drug treatment. Pharmacogenomics. 2021;22(15):959-962. https://doi.org/10.2217/pgs-2021-0088 DOI: https://doi.org/10.2217/pgs-2021-0088
65. Cross JL, Choma MA, Onofrey JA. Bias in medical AI: Implications for clinical decision-making. PLOS Digit Health. 2024;3(11):e0000651. https://doi.org/10.1371/journal.pdig.0000651 DOI: https://doi.org/10.1371/journal.pdig.0000651
66. Kothinti RR. Artificial intelligence in healthcare: revolutionizing precision medicine, predictive analytics, and ethical considerations in autonomous diagnostics. World J Adv Res Rev. 2024;24(3):3394-3406. https://doi.org/10.30574/wjarr.2024.24.3.3675 DOI: https://doi.org/10.30574/wjarr.2024.24.3.3675
67. Karnwal A, Rehman AU, Jassim AY, Kumar G, Al-Tawaha ARMS, Nesterova N. Artificial intelligence in cancer diagnosis and therapy using sex and gender as precision biomarkers. Discov Oncol. 2026;17(1):1049. https://doi.org/10.1007/s12672-026-05256-x DOI: https://doi.org/10.1007/s12672-026-05256-x
68. Alagiakrishnan K, Halverson T, Olivares DVF, Sadowski CA. New personalized medicine model for medication management. J Pers Med. 2026;16(4):182. https://doi.org/10.3390/jpm16040182 DOI: https://doi.org/10.3390/jpm16040182
69. Jarman AF, Wolfe MG, Mumma BE, Madsen TE, Safdar B, Greenberg MR, et al. The role of sex and gender in precision emergency medicine: a scoping review and proposed hierarchy. Clin Ther. 2024;46(12):974-981. https://doi.org/10.1016/j.clinthera.2024.10.007 DOI: https://doi.org/10.1016/j.clinthera.2024.10.007
70. Bonkhoff KA, Coughlan G, Perosa V, et al. Sex differences in age-associated neurological diseases—A roadmap for reliable and high-yield research. Sci Adv. 2025;11(10):eadt9243. https://doi.org/10.1126/sciadv.adt9243 DOI: https://doi.org/10.1126/sciadv.adt9243
71. Gogovor A, Zomahoun HTV, Ekanmian G, Adisso EL, Tardif AD, Khadhraoui L, et al. Sex and gender considerations in reporting guidelines for health research: a systematic review. Biol Sex Differ. 2021;12(1):62. https://doi.org/10.1186/s13293-021-00404-0 DOI: https://doi.org/10.1186/s13293-021-00404-0
72. Khoharo HK, Shaikh DM, Nizamani GS, Shaikh TZ, Ujjan I, Uqaili AA. Effects of Berberine on Blood Glucose, Glycated Hemoglobin A1, Serum Insulin, C-peptide, Insulin Resistance and β-cell Physiology. J Pharm Res Int. 2020;32(36):36–41. https://doi.org/10.9734/JPRI/2020/v32i3630988 DOI: https://doi.org/10.9734/jpri/2020/v32i3630988
73. Talpur RA, Meghji KA, Uqaili AA, Kazi N, Nizammani GS, Qazi S. Anti-hyperglycemic and anti-oxidative effects of L-carnitine administration in alloxan induced diabetic albino Wistar rats. Khyber Med Univ J. 2019;11(4):204–208. https://doi.org/10.35845/kmuj.2019.19115 DOI: https://doi.org/10.35845/kmuj.2019.19115
74. Shaikh S, Malik F, Uqaili AA. Effect of aescin on β-cell physiology in fructose fed rat model. Ann PIMS. 2020;16(1):15–19. https://doi.org/10.48036/apims.v16i1.265
75. Naeem A, Bhatti U, Batool S, Shaikh K, Uqaili A, Rani K. Association of vitamin D with obesity in premenstrual syndrome: A study of female population of Hyderabad, Sindh. Pak J Med Health Sci. 2022;16(11):656. https://doi.org/10.53350/pjmhs20221611656 DOI: https://doi.org/10.53350/pjmhs20221611656
76. Mahar B, Shah T, Shaikh K, Shaikh SN, Uqaili AA, Memon KN, et al. Uncovering the hidden health burden: a systematic review and meta-analysis of iron deficiency anemia among adolescents, and pregnant women in Pakistan. J Health Popul Nutr. 2024;43(1):149. https://doi.org/10.1186/s41043-024-00643-y DOI: https://doi.org/10.1186/s41043-024-00643-y
Published
Issue
Section
License
Copyright (c) 2026 Muhammad Arsalan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Women's Health, Reproductive Medicine and Physiology (JWHRMP) follows the Attribution Creative Commons-Non commercial (CC BY-NC 4.0) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC BY-NC 4.0 license restricts the use of material for commercial purposes (Further details are available at website. The Editorial Board of the JWHRMP endeavors to ensure the accuracy, integrity, and quality of all published content. However, the responsibility of opinions, interpretations, and conclusions expressed in the published articles rests entirely with the authors and do not necessarily reflect the views of the Editorial Board, publisher, or affiliated institutions.
